Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6125)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2020 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarao K, Nozaki A, Komatsu H, Komatsu T, Taguri M, Tanaka K, Chuma M, Numata K, Maeda S. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World J Hepatol 2020; 12(11): 1046-1054 [PMID: 33312428 DOI: 10.4254/wjh.v12.i11.1046] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i11/1046.htm |
| Number | Citing Articles |
| 1 |
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
|
| 2 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
|
| 3 |
Yang Yang, Guangbing Li, Ziwen Lu, Yong Liu, Junjie Kong, Jun Liu. Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.726213
|
| 4 |
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09514-3
|
| 5 |
Tanita Suttichaimongkol, Manoon Mitpracha, Kawin Tangvoraphonkchai, Phuangphaka Sadeea, Kittisak Sawanyawisuth, Wattana Sukeepaisarnjaroen. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. Journal of Circulating Biomarkers 2023; 12: 12 doi: 10.33393/jcb.2023.2453
|
| 6 |
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka, Testuo Yoshida, Hideki Koyasu, Makoto Chuma, Kazushi Numata, Shin Maeda. Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma. World Journal of Hepatology 2021; 13(6): 699-708 doi: 10.4254/wjh.v13.i6.699
|
| 7 |
Nia Adeniji, Renumathy Dhanasekaran. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatology Communications 2021; 5(12): 1972 doi: 10.1002/hep4.1823
|
| 8 |
Amina Tawfik, Samia Shouman, Reda Tabashy, Mervat Omran, Mohamed Gad El-Mola. Evaluation of doxorubicin administrations in hepatocellular carcinoma in terms of genetic polymorphism, case study: Egypt. Arab Gulf Journal of Scientific Research 2024; 42(4): 1609 doi: 10.1108/AGJSR-04-2023-0158
|